Suspected drug reaction with piperacillin/tazobactam, in a premature infant

British Journal of Clinical Pharmacology

Volumn 65, Issue 6, 2008, Pages 971-972

  Maulidi, Halima ^a   Godambe, Sunit ^a   Chow, Peter ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; PORACTANT; STEROID;

AGRANULOCYTOSIS; BLOOD CULTURE; CASE REPORT; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; INFANT; LETTER; MALE; NEWBORN SEPSIS; PREMATURITY; PRIORITY JOURNAL; RASH;

ANTI-BACTERIAL AGENTS; EXANTHEMA; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; PENICILLANIC ACID; PIPERACILLIN; SEPSIS;

EID: 43549119243     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2008.03105.x     Document Type: Letter

References (5)

1. Carroll MC, Yueng-Yue KA, Esterly NB, Drolet BA. Drug induced hypersensitivity syndrome in pediatric patients. Pediatrics 2001 108: 485 92.
2. Zosyn (Piperacillin/tazobactam). Welcome to Zosyn. Wyeth pharmaceuticals Inc., Philadelphia, 2006. Available at: http://www.zosyn.com/homepage.asp (update May 2006; cited March 2007).
3. Berger A, Kretzer V, Apfalter P, Rohrmeister K, Zaknun D, Pollak A. Safety evalutation of piperacillin/tazobactam in very low birth weight infants. J Chemother 2004 16: 166 71.
4. Flidel-Rimon O, Friedman S, Leibovitz E, Shinwell ES. The use of piperacillin/tazobactam (in association with amikacin) in neonatal sepsis: efficacy and safety data. Scand J Infect Dis 2006 38: 36 42.
5. Grieco T, Cantisani C, Innocenzi D, Bottoni U, Calvieri S. Acute generalised exanthematous pustulosis caused by piperacillin/tazobactam. J Am Acad Dermatol 2005 52: 732 3.